Demonstrating efficacy and value for one-and done therapies
25 Sep 2024
Muir Woods
Gene Therapy Development
- How to overcome immunological barriers in AAV gene therapy?
- How to minimize genotoxicity in high dose treatments?
- How to improve cost/benefit ratio of gene therapy products?
Industry Expert
